Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors

Zainab M. Elsayeda Scientific Research and Innovation Support Unit, Kafrelsheikh University, Kafrelsheikh, EgyptView further author information

Hadia Almahlib Department of Chemistry, University of Cambridge, Cambridge, UKView further author information

Alessio Nocentinic Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Firenze, ItalyView further author information

Andrea Ammarac Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Firenze, ItalyView further author information

Claudiu T. Supuranc Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Firenze, ItalyCorrespondence[email protected]

https://orcid.org/0000-0003-4262-0323 View further author information

Wagdy M. Eldehnad Department of Pharmaceutical Chemistry, Kafrelsheikh University, Kafrelsheikh, Egypt;e School of Biotechnology, Badr University in Cairo, Badr City, Cairo, EgyptCorrespondence[email protected]

https://orcid.org/0000-0001-6996-4017 View further author information

Sahar M. Abou-Serif Department of Pharmaceutical Chemistry, Cairo University, Cairo, EgyptCorrespondence[email protected]
View further author information

show all

Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date